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Abstract 
 The concern of a Cryptosporidium or Giardia waterborne outbreak due to 
treated wastewater has had water treatment utilities using some of the highest 
water cleansing technologies available. Cryptosporidiosis and Giardiasis are 
severe diarrheal diseases which can lead to death, thus it is important that 
appropriate steps are taken to assure these parasites are not present in the 
effluent of treated wastewater. This study examined the results of 863 assays for 
Giardia and Cryptosporidium on the effluent of wastewater treatment facilities 
and found that county of collection, watershed of collection, and laboratory 
analyzing the sample have the most significant impact on the detection of 
Cryptosporidium oocysts and Giardia cysts in wastewater effluent and that there 
were minimal but significant differences in method of treatment and method of 
filtration. To date no other comprehensive analysis of this data has been done.  
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Introduction 
Cryptosporidium  
 Cryptosporidium is a protozoan coccidian parasite of the apicomplexa 
phylum found in the respiratory and gastrointestinal tracts of many hosts.  
Cryptosporidium species are ubiquitous in nature with worldwide distribution and 
have mammalian, avian, piscine, and amphibian hosts (Fayer, 2010). 
Cryptosporidium oocysts can be found in soil, surface water, recreational water, 
drinking water, and fecal-contaminated food. 
 Although many hosts are capable of acquiring this organism, it is thought 
that the main environmental reservoirs for this organism are cattle and rodents 
(Chalmers et al 1997). Cryptosporidium has been a recognized cause of disease 
for over a century but has widely garnered attention in the US since the 1970s as 
an increasing cause of infectious disease. Cryptosporidium was recognized as a 
disease causing parasite in 1907 by E.E. Tyzzer in mice and has been commonly 
detected by veterinarians ever since (U.S. E.P.A., 2001). The first episode of 
cryptosporidiosis in a human was recorded by Nime in 1976, in a 3-year old girl 
in Tennessee. Since then, the incidence and prevalence of this organism have 
been increasing. A large part of this is due to the discovery that much of the fatal 
diarrheal diseases in HIV and AIDS patients is caused by Cryptosporidium (Kim 
et al, 1998).  Healthy individuals exhibit symptoms ranging from asymptomatic to 
severe, but the infection is almost always fatal in immunocompromised patients 
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(Pieniazek, et al, 1999). This has been a leading cause for a major portion of the 
studies of Cryptosporidium species and pathogenesis as well studies for 
increasing the efficacy of diagnostic testing.   
 Cryptosporidiosis is a mainly zoonotic disease transmitted to humans from 
various mammals, birds, reptiles, and rodents through the fecal-oral route. It has 
also been demonstrated to be an anthroponotic disease further adding to its 
ability to be easily transmitted. The current number of species and the specific 
described genotypes varies constantly as they are described and identified 
through by polymerase chain reaction (PCR) and gene sequencing (Champliaud, 
et al, 1998). Methods for serological testing for antibodies to Cryptosporidium sp. 
have been effective in detecting different species of this organism from a variety 
of hosts (Priest, et al, 2006). Over 40 genotypes and 15 species of 
Cryptosporidium have been described (Ruecker, et al, 2007). Although there 
have been several species of Cryptosporidium there are currently eight that have 
been found to be infective to and pathogenic in humans: C. parvum, C. hominis, 
C. meleagridis, C. felis, C. canis, C. muris, C. suis and C. corvine (Kosek, et al, 
2001). Of these species C. parvum, C. hominis, and C. meleagridis, respectively, 
are the organisms that cause the highest levels of disease in humans. An 
increasing number of species are being proven to infect humans, including 
strains thought as only host specific (Xiao, et al, 2001). 
 The species causing the highest rate of disease in humans is C. parvum  
although C. hominis is considered to be the human specific species. Most 
mammals are infected with host-specific species of Cryptosporidium. These are 
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generally infections throughout a domesticated animal community. Some wild 
mammals can become infected by another host-specific species through 
practices such as coprophagia, a demonstrated common behavior in foxes. The 
most likely explanation for this is that C. parvum is a widely infective species and 
is hosted by a variety of domesticated animals. Cows are a known host of this 
organism and transmission is thought to occur by general contact as well as 
through the ingestion of unpasteurized milk. Once infected, this organism is 
easily spread from human to human (Pieniazek, et al, 1999). 
 A topic of controversy has been the exact route through which humans are 
infected with this organism. The main question is whether the specific organisms 
are being shed by animals in water that eventually comes into contact with 
drinking water or if transmission occurs by another route. There have been 
several studies demonstrating the connection between Cryptosporidium 
harboring wild mammals and the occurrence of Cryptosporidium oocysts in runoff 
and storm water (Cizek et al, 2008) (LeChevallier, Norton, & Lee, 1991). Hence 
these animals can be a source of Cryptosporidium in watersheds and source 
water (U.S. E.P.A., 2001). Zhou, et al (2004) found that animals inhabiting areas 
where possible watershed contamination is present, were shown to be infected 
by species that cause no known illness in humans. To date few studies 
determining the differing concentrations of Cryptosporidium species infectious to 
humans in water sources have been completed. While non-pathogenic species 
may infect watersheds, and thus can be detected by the current standard assay, 
USEPA Method 1623, the ratio of non-pathogenic to pathogenic is not known 
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(Ruecker, et al, 2007). Any detection of Cryptosporidium oocysts can be seen as 
a public health threat.  
 After infection with Cryptosporidium some people may be completely 
asymptomatic while still shedding high levels of oocysts. For most infected 
people,the symptoms of watery diarrhea, stomach pain or cramps, dehydration, 
nausea, vomiting, fever, and weight loss start seven to ten days after being 
infected. These symptoms usually persist for one to two weeks, but can range 
from a few days to several weeks. In otherwise healthy immunocompetent 
persons the disease and infection is self-limiting (Pieniazek, et al, 1999). During 
the complicated lifecycle there is the possibility of autoinfection and thus patients 
may have symptoms that come and go for a period lasting up to a month.  
 When the immune system is compromised or the infected person has 
another infection or disease, the Cryptosporidium infection may last longer and 
have more severe symptoms (Pozio, et al, 1997). In many HIV positive and AIDS 
patients cryptosporidiosis is a fatal disease causing unrelenting diarrhea 
(Pieniazek, et al, 1999).  
 An infected host sheds the infectious thick-walled oocysts of 
Cryptosporidium which then contaminates food and water sources. The 
complicated lifecycle of Cryptosporidium begins with ingestion of the thick-walled 
oocysts. The oocyst releases sporozoites which then invade the lumen and lungs 
and undergo asexual reproduction. The sexual reproduction phase then takes 
place with the female macrogamonts and male microgamonts resulting in 
fertilization. The following zygote develops into thin-walled oocysts that autoinfect 
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the host and thick-walled oocysts that exit the host through feces (Current & 
Garcia, 1991).  
 Cryptosporidiosis diagnosis is done with various microscopy, staining, and 
antibody detection procedures used to detect oocysts in feces. Multiple staining 
techniques such as an acid-fast staining, giemsa staining, and auramine staining 
can be used to detect oocysts. Tissue biopsies of the small intestine can be 
stained with hematoxylin and eosin which shows oocysts attached to the 
epithelial cells. Antigen/antibody detection techniques such as direct fluorescent 
antibody (DFA), immunofluorescent assays enzyme-linked immunosorbent assay 
(ELISA), and polymerase chain reactions (PCR) are extremely useful in 
diagnosis (Jex, et al, 2008). 
 There is no proven preventative or curative treatment for cryptosporidiosis 
(U.S. E.P.A. 2001), but nitazonaxide and parmomycin are showing promise in 
treatment of cryptosporidiosis (Chakrabarti and Chakrabarti, 2009). While 
mammalian infections caused from Cryptosporidium are generally limited to the 
gastrointestinal tract, there have been respiratory tract infections caused by this 
organism as well. Respiratory tract infections have been found in avian and 
mammalian species (Akiyoshi et al, 2003). Cama in 2007 noted that HIV-positive 
patients commonly acquire the respiratory version of this disease (Cama, et al, 
2007). Studies, such as that of Mercado et al (2007) and Mor et al (2010),  
indicate the potential for transmission of Cryptosporidium by respiratory 
secretions. Those studies also demonstrate that healthy immunocompetent 
people testing positive for gastrointestinal Cryptosporidium have also tested 
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positive for Cryptosporidium in their sputum.  In a study of 926 children in 
Uganda by Mor et al. (2010), Cryptosporidium DNA was found in the sputum of 
35% of the children who were positive for gastrointestinal Cryptosporidium. Of 
those children, 94% of them were HIV-seronegative. In the control population of 
children who were negative for gastrointestinal Cryptosporidium and tested for 
respiratory Cryptosporidium 100% of them were negative for respiratory 
Cryptosporidiosis. In this study, the sputum was analyzed by molecular methods 
for the detection of Cryptosporidium DNA; microscopic assays for the detection 
of Cryptosporidium oocysts or sporozoites were not performed. This means while 
present in the respiratory tract Cryptosporidium may not be transmissible by 
respiratory secretions. There has been no evidence found that respiratory 
Cryptosporidium is caused by gastrointestinal cryptosporidiosis. The third most 
common species of Cryptosporidium to infect humans, C. meleagridis, is the 
most common organism found in many avian species. In several studies 
respiratory transmission of this organism in avian species has been established. 
This species of Cryptosporidium has been shown to infect humans as well as 
avian species and infects non-human species primarily by respiratory secretions 
(Akiyoshi, 2003). Since this leads to the possibility of a higher than known 
respiratory transmission of Cryptosporidium, further examination of the possible 
public health threats this poses is warranted.  
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Giardia 
 Giardia duodenalis, also known as G. lamblia and G. intestinalis, is a 
flagellated protozoan parasite in the Metamonada phylum. Giardia is ubiquitous 
worldwide with a wide range of mammalian and avian hosts. There are an 
estimated 2.5 million cases of Giardiasis annually. While the highest burden of 
disease caused by Giardia is in developing countries, in developed countries 
Giardia is the most prevalent intestinal parasite (Furness, 2000). Humans are a 
main reservoir for Giardia although it is found in many small aquatic and semi-
aquatic mammals (Baker, 2007).  Giardia can be found in surface water, lake and 
pond water, water from shallow wells, and recreational water facilities such as 
pools, beaches, and fountains. As with Cryptosporidium, Giardia is a zoonotic 
disease (Feng & Xiao, 2011). Different infective species of Giardia have been 
found in cats, dogs, cattle, deer, and beavers. Numerous cases of campers 
acquiring the disease from water inhabited by beavers have given this disease 
the nickname “beaver fever”. 
 Giardia was first noted by Antony van Leeuwenhoek in 1681 after an 
examination of his own fecal matter. In 1859 Vilem Lambl described and 
illustrated its morphology and was again described in 1895 by Alfred Giard. Over 
two centuries since its first description passed before Giardia was associated 
with diarrheal diseases in 1902 by Charles Stiles (Cox, 2002). In 1954 Rendtorff 
officially linked the parasite with diarrheal disease.  
 Over 40 species of Giardia have been described but only six 
morphologically distinct species are recognized: G. lamblia, G. muris, G. ardeae, 
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G. psittaci, G agilis, and G. microti.  The species G. lamblia is the main species 
thought to infect humans. G. lamblia, G. microti, and G. muris are found in 
mammals, G. ardeae and G. psittaci in birds, and G. agilis has been isolated 
from amphibians. Many species of Giardia appear morphologically identical and 
thus naming and identifying different species has been difficult (Adam, 2001).  
 A Giardia infection starts with the ingestion water or food that has been 
contaminated with fecal matter containing cysts. Once a cyst is ingested 
excystation occurs in the stomach or in the duodenum. The excysted 
trophozoites undergo asexual reproduction through binary fission in the small 
intestines. At this point some of the trophozoites continue to asexually reproduce 
causing autoinfection. The rest of the trophozoites encyst while in the large 
intestines and get passed through the remainder of the digestive tract in feces. 
While trophozoites and cysts get passed out of the body in feces only the cyst 
form is able to survive outside the host (Adam, 2001).  
 Unlike Cryptosporidium, Giardia only colonizes the lumen of an infected 
host. The major of infections are asymptomatic but they can cause acute or 
chronic diarrheal illnesses. The primary symptoms of infection are diarrhea, 
malaise, foul smelling flatulence, steatorrhoea (pale, foul, greasy stools), 
abdominal cramps, bloating, nausea, vomiting, and weight loss start one to three 
weeks after exposure. Giardiasis is generally a self-limiting disease with 
dehydration being the main health concern (Gardner & Hill, 2001).  
 Diagnosis of Giardiasis entails an ova and parasite examination of feces 
that is routinely repeated for a total of three specimens. Cyst detection from feces 
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aids in diagnosis in over 80% of patients. While ELISA assays are available, they 
are much more costly and should not take the place of stool examination. A 
majority of Giardiasis cases can be treated with anti-parasitic nitroimidazole 
medications (Gardner and Hill, 2001). Because of the dramatic fluid loss 
Giardiasis induced diarrhea can cause a main component of treatment is fluid 
and electrolyte management (Guerrant et al 2001). When the immune system is 
compromised or the infected person has another infection or disease, the 
infection may last longer and have more severe symptoms, but unlike 
Cryptosporidium it is not usually fatal as effective treatment therapies are widely 
available (Gardner & Hill, 2001).  
. 
Cryptosporidium and Giardia Water Safety Threat 
 The infectious oocysts and cysts of Cryptosporidium and Giardia, 
respectively, are found in the feces of infected animals (Hunter & Thompson, 
2005). Both Cryptosporidium and Giardia are organisms that pose a health threat 
in developed, as well as developing, countries. The World Health Organization 
placed these parasites on its list of neglected diseases due to the need for further 
preventative and treatment method research (Chakrabarti and Chakrabarti, 
2009).  
 The main public health threat currently posed by these organisms is a 
waterborne outbreak. Cryptosporidium and Giardia concerns arise because: they 
are easily spread through ingestion of contaminated drinking water, recreational 
water, and food; easily spread by fecal-oral routes involving animals and soil; and 
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Cryptosporidium is highly resistant to disinfection by chlorination at levels that are 
not toxic to people (Kosek, et al, 2001). Due to these concerns both organisms 
have been labeled as Category B Bioterrorism Agents. A Category B 
Bioterrorism Agent is defined as an agent that is moderately easy to disseminate, 
results in moderate morbidity and low mortality rates, and requires specific 
enhancements of the CDC’s diagnostic capacity and enhanced disease 
surveillance. Some examples of other Category B agents are brucella, epsilon 
toxin (clostridium perfringens), salmonella, E. coli 0157:H7, Q fever, ricin toxin, 
typhus fever, and other water safety threats (Rotz et al, 2002).  
 An example of the devastating effects of an outbreak (not due to 
bioterrorism) is the 1993 waterborne outbreak of Cryptosporidium in Milwaukee, 
Wisconsin. The outbreak occurred as a result of ineffective water filtration of a 
municipal potable water supply. While the obvious health effects of this outbreak 
were monitored it is one of the few Cryptosporidium outbreaks that had a 
retrospective cost-of-illness analysis. An estimated 403,000 people become ill 
and 104 died with the total cost of illness being approximately $96.2 million: 
$31.7 million in direct medical costs and $64.6 million in productivity losses 
(Corso, et al, 2003). In 1998 the main water supply in Sydney, Australia was 
contaminated with Cryptosporidium and Giardia, affecting over three million 
residents (Stein, 2000). In Florida there have been over 1,000 cases of 
Giardiasis reported annually for more than a decade. In 2006 a neighborhood 
water fountain became contaminated resulting in an outbreak with 38 cases of 
Giardiasis, 9 cases of cryptosporidiosis, and 2 cases of co-infection (Eisenstein, 
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Bodager, & Ginzl, 2008). According to the US EPA almost all of the 
Cryptosporidium outbreaks in the US after 1985 occurred as a result of a fault in 
treatment and/or filtration of water (US EPA, 2001). It is apparent that 
cryptosporidiosis and Giardiasis are diseases of major concern due to their 
health and economic impacts. 
 Enhanced water purification protocols were put into place in an effort to 
stem the spread and occurrence of Giardia and to prevent Cryptosporidium from 
getting into any potable water source. As both of these diseases are generally 
spread in a fecal-oral route, the highest degree of action was taken in the 
treatment of source water and wastewater that are open to the environment. 
Current requirements apply to public water systems that use ground or surface 
water that is under the direct influence of surface water, the types of water that 
are most susceptible to protozoan contamination.   
  In 1974 the U. S. Congress enacted the Safe Drinking Water Act as a 
public health measure to assure the safety of the nation’s drinking water supply. 
The regulations enacted examine chemical, microbiological, physical, and 
radiological contamination in water. This act was later amended and in 1989, 
Giardia was added as a contaminant for regulation. In 1998 the Interim 
Enhanced Surface Water Act was created to further control Cryptosporidium. The 
long Term 1 Enhanced Surface Water Treatment Rule was enacted in 2002 and 
lead to the current Long Term 2 (LT2) Enhanced Surface Water Treatment Rule 
developed in 2006. The goal of these rules is to control microbial pathogens in 
water while minimizing the public health risks of disinfectants, disinfection 
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byproducts, and chemical contaminants. Under the LT2 rule, source water 
treatment facilities must submit monthly samples for two years or semimonthly 
samples for one year for examination of Cryptosporidium and Giardia if they fail 
initial E. coli coliform or state-approved alternate indicator monitoring. If the levels 
of E. coli detected exceed the acceptable limits source water monitoring of 
Cryptosporidium is required.  
 The Safe Drinking Water Act Amendments of 1996 require the US EPA to 
evaluate public health risks posed by drinking water contaminants including the 
parasites Cryptosporidium and Giardia.  The US EPA is responsible for 
assessing the parasite occurrence in raw surface waters used as source water 
for drinking water treatment plants. EPA Method 1623 was designed as the 
detection method for Cryptosporidium and Giardia in water from the treatment 
plants. The results were submitted to the US EPA for the purpose of monitoring 
the source water and to determine if additional treatment is required. This is 
essential to monitor increases in microbial risk that may occur when systems 
implement the Stage 2 Disinfectants and Disinfection Byproducts Rule (Stage 2 
DBPR). Depending on the results of the tests facilities may have to install new or 
additional treatment and filtration systems as well as submit additional samples 
for testing. E. coli detection is enacted first as a cost saving method due to the 
high costs of collection and analysis of water samples for Cryptosporidium and 
Giardia. Price variance occurs between labs,  but in general a total coliform 
analysis costs less than $70 while EPA Method 1623 Cryptosporidium and 
Giardia testing costs over $500. E. coli coliform testing detects the presence of 
  
13
fecal contamination in water. As Cryptosporidium and Giardia are passed into 
water through contaminated feces monitoring first for the presence of fecal 
contamination is a time and cost saving measure. In order to assure that steps 
taken to minimize cyst and oocysts presence in the wastewater effluent are 
successful facilities that have had a positive test result are required to submit 
subsequent samples for testing in a sped-up timeframe until they have negative 
results.  
 The different policies enacted monitor potable and surface water sources 
primarily due to the use of reclaimed water. While the US EPA has established 
guidelines for reclaimed water it does not regulate its use. Regulation is left to 
each individual state and the state’s interpretation of the guidelines, leading to 
varying definitions and uses. Reclaimed or “reuse” water is considered to be 
wastewater (sewage) that is treated to remove certain solids and impurities. The 
practices of “re-using” water were implemented to ensure freshwater 
conservation and sustainability for the alleviation of water shortages (Levine and 
Asano, 2004). The increasing municipal water demand in populated areas is 
another reason wastewater reclamation is being enacted.  Reclaimed water is 
not treated to the same degree as potable water before use. Thorough treatment 
methods are needed to ensure that there is no contamination by Cryptosporidium 
and Giardia. Reclaimed water that is not properly treated may contain infectious 
cysts and oocysts. Reclaimed water is used for fire suppression, dust control, 
and irrigation of agricultural and recreational areas such as golf courses, 
playgrounds, and public parks. Agricultural use of contaminated reclaimed water 
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can lead to contaminated food. Recreational irrigation with contaminated 
reclaimed water can lead to increased exposure to humans. According to one 
statistic EPA released online: approximately 673 million gallons per day of 
reclaimed water was reused for beneficial purposes in 2009 in Florida. This 
highlights the importance of monitoring wastewater effluent in order to decrease 
any possible transmission of protozoan parasites to humans.   
 
Wastewater Treatment 
 Many different methods are utilized in the treatment of wastewater, but 
almost all of them are 5-stage biological nutrient removal (BNR) processes. BNR 
removes nitrogen and phosphorus from wastewater through the use of various 
microorganic conditions (U.S. E.PA, 2007). The 5-stage BNR process has been 
shown to remove more wastewater nutrients, such as nitrogen, phosphorus, and 
oxygen, and thus provides better treatment of the water (Uygur, 2004). Often the 
activated sludge method is used in treatment due to its role in the breakdown of 
biomass (Fenu, et al, 2010) and its relative simplicity (Vigne, et al, 2010). 
Through a series of aerobic, anaerobic, and anoxic tanks carbon, nitrogen, 
phosphorus, metals, and pathogens are removed from the water (Song, et al, 
2010; Bok, et al, 2002). Throughout each stage several biochemical reactions 
take place in the treatment of various contaminants (Goel, et al, 1998). The 
anaerobic stage is primarily responsible for pathogen removal (Novak, et al, 
2010).  
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 Tertiary treatment, such as filtration and disinfection, are necessary for 
removal of microorganisms from wastewater systems (Koivunen, 2003). Through 
the entire process most of the microorganisms in the water are removed in the 
filtration stage.  To date no filtration method has been developed that is capable 
of eliminating all of the cysts and oocysts; the best methods filter out 99% of 
Cryptosporidium oocysts (U.S. E.P.A., 2001).  
 Continuous backwash filtration is a method of water filtration that employs 
granular media filter beds. The basic principle is that effluent water flow is 
reversed in a section of the filter bed media and pumped through the media in 
the opposite direction of regular flow (England, 1994). This dislodges waste from 
the media and mixes the media to a more optimal density allowing better water 
flow and filtration. In most systems the backwash water is discarded due to the 
high amount of waste in it. Backwash water is commonly discarded by 
discharged into a sanitary sewer, transport to a sewer plant or landfill, or sent to 
a basin where the solids are settled out. It is also mixed with the plant influent 
and re-cycled through the plant. All of the methods for disposal of backwash 
water are highly regulated due to the presence of contaminants.  A continuous 
backwash method keeps the filter media from getting clogged and also 
eliminates the need to shut down for filter cleaning. It also eliminates the rush of 
“dirty” water that happens when the flow is restored.  
 A method that is gaining popularity is continuous backwash, upflow, deep 
bed, granular media (sand) filtration. This combines several proven effective 
filtration methods into one system. Influent water is pumped into the central feed 
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chamber of the tank. From there it is injected into the bottom layer of granular 
media and flows upward to the top of the tank. As the water travels upward the 
waste is caught in the media. The water is cleaned during the entire travel 
through the media because the sand is clean at the top of the tank. The heavy 
waste-laden sand sinks to the bottom of the tank, as it sinks to a level below the 
influent injection it is pumped vertically through an airlift where it is heavily 
scoured and the waste is removed. Once the sand reaches the top of the airlift it 
flows into a reject compartment where the lighter weight waste floats into the 
reject pipe as the sand falls into the washbox. Due to the difference in water level 
between the filtrate pool and the reject weir a small amount of polished water 
flows upward creating a counter-current that carries the remaining waste back 
into the reject weir while further cleaning the returning sand. The clean sand falls 
out of the washbox and forms the top layer of the media bed. This process allows 
for influent water to constantly flow through continuously cleaned sand while it is 
filtered (England, Darby, and Tchobanoglous, 1994).  
 Shallow bed backwash systems in use have a media depth of one to two 
feet and are generally traveling bridge systems. These systems can be 
continuous backwash systems but are generally downflow as opposed to the 
upflow system mentioned previously. While the upflow methods utilize narrow, 
deep beds downflow methods utilize a wide, shallow horizontal media bed. 
Systems that are not continuous backwash need to have cells routinely shut 
down for a backwash when necessary. As this process can lead to large drops in 
water pressure, can be extremely time consuming, and is not optimal for large 
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systems, it has been losing popularity (England, Darby, and Tchobanoglous, 
1994). Larger facilities with shallow bed filters can be continuous backwash 
facilities when employing a traveling bridge filter. A traveling bridge filter does not 
require periodic shut down and it does not use backwash water holding tanks. 
The traveling bridge moves along the media bed and backwashes one section at 
a time.  
 Deep bed multimedia filtration consists of granular media that is over four 
feet deep. Most deep bed filters are downflow with layers of granules that are 
consecutively smaller in diameter with each new layer. The media most 
commonly used in various multimedia filters are sand, anthracite, garnet, 
ilmenite, alumina, and magnetite (Sutherland, 2009). The number and amounts 
of different media used varies with each facility. The cost of each media as well 
as transportation and storage costs of high density media are factors for 
determining the media used. Anthracite coal is widely used because it has a 
unique density allowing it to stay above other filter mediums easily, it has high 
carbon content, and its low uniformity allows for differing levels of solid waste 
penetration resulting in high flow rate and prefiltration. Granulated garnet is used 
because it has some of the same properties as anthracite and is a high density 
media. Ilmenite is used to promote coagulation. Alumina is used primarily as a 
flocculating agent and also reduces the amount of fluoride in the water. 
Coagulation and flocculating agents are important as they cause organic 
materials to agglomerate forming larger and heavier particles which are then 
caught in the various filters. Magnetite is used as a sorbent for arsenic. As the 
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water flows through the media it is cleaned and the polished effluent exits at the 
bottom of the tank.  Backwashing for these systems is an involved and time 
consuming process as clean water is pumped backward through the filter to 
dislodge waste. The waste is resuspended resulting in a highly contaminated 
liquid that must be specially disposed of.   
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Statement of the problem 
  The purpose of this study was to determine if county of collection, 
watershed of collection, facility of collection, method of treatment, method of 
filtration, and laboratory examining the sample were factors in the quality of 
wastewater effluent through the presence of Cryptosporidium oocysts and 
Giardia cysts in samples submitted for testing. 
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Materials and Method 
 From 1998 to 2010 there were 234 facilities that submitted samples to 11 
different laboratories for testing to detect Cryptosporidium oocysts and Giardia 
cysts. The 863 samples selected were samples that had been analyzed for both 
Cryptosporidium and Giardia. All of those samples were from effluent of 
wastewater facilities and thus were from facilities that may pose a public health 
risk if their effluent was contaminated. The records for the following information 
were reportedly submitted and recorded when samples were submitted: facility 
name, address, identification number, and permit number; facility water treatment 
and water filtration methods; sample collection, submission, and analysis dates; 
organization collecting the sample; organization analyzing the sample; and the 
sample results. Due to discrepancies such as submitters filling out submission 
inadequately, incorrectly and/or inconsistently not all of the information was 
available. Information for the total daily volume and capacity for each facility at 
the time of sample collection was not tracked and thus was not examined.  
 Linear multivariate regression analysis of the different variables was 
unable to be done due to multiple gaps in information. The results obtained were 
from different databases for sample information, facility information, and contact 
information.  The information for facility size and capacity was not enough for 
significant data to be obtained. Because there was such a scarcity of information 
for facility size and capacity in general, let alone the specific size and capacity of 
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the facility at the time the sample was collected, no analysis of impact of the 
facility size and capacity was able to be done. Unless otherwise stated the 
program used to compile and compare the data was Microsoft Excel 2003. With 
this program charts, pivot tables, percentages, sums, linear regression lines, and 
correlation coefficients were done. 
 In order to properly compare the different factors involving quality of 
wastewater effluent supplemental data for county of collection, watershed of 
collection, county population, and rate and incidence of cryptosporidiosis and 
Giardiasis per county were needed. The county for each facility was determined 
using the facility address and the county boundaries as defined by the State of 
Florida. The watershed of each sample was determined by comparing the facility 
collection address with the boundaries of the 29 major watersheds of Florida as 
defined by The Florida Water Resource Management Division and Environmental 
Assessment and Restoration Division of the Florida Department of Environmental 
Protection (FL DEP, 2011). Information for the population per county, rates of 
disease, and counts of disease were obtained from the Florida Community 
Health Assessment Resource Tool Set established by the Florida Department of 
Health Office of Health Statistics and Assessment (FLCHARTS, 2011).  
 Starting in the 1990s the EPA evaluated methods for the detection, 
monitoring, and analysis of Cryptosporidium. The first procedure adopted was 
the Information Collection Rule (ICR) Protozoan Method for Detecting Giardia 
Cysts and Cryptosporidium Oocysts in Water by a Fluorescent Antibody 
Procedure in 1995 (U.S. E.P.A., 1995). Method 1622 was released as final in 
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1999, then updated in 2005 but it only included detection for Cryptosporidium 
(U.S. E.P.A., 2005). In 1999 a revised method for simultaneous detection of 
Cryptosporidium and Giardia, Method 1623, was validated and released (U.S. 
E.P.A., 1999). Both Method 1622 and Method 1623 were revised in 2001 with 
method updates including new filter and antibody stain components, clarified 
sample acceptance criteria, modified sample testing procedures, updated quality 
control acceptance criteria, and inclusion of spiking suspensions. To support the 
Long Term 2 Enhanced Surface Water Treatment Rule revisions to both Method 
1622 and Method 1623 were made in 2003 and 2005 (U.S. E.P.A. Method 1622, 
2005) (U.S. E.P.A. Method 1623, 2005). The 2003 revisions included a modified 
version of the methods using a new type of filter, approval oocysts and cysts for 
quality control samples from a different manufacturer, new rejection criteria for 
samples, guide for measuring sample temperatures, quality control sample 
requirements and results clarification, guidance for staining slides, and other 
minor corrections. For 2005 the revisions include approval of a continuous-flow 
centrifugation method, addition of a new monoclonal antibody stain, and 
clarification of analyst verification and sample condition criteria. The sample 
collection, storage, and analysis procedures changed by varying degrees with 
each revision. Due to these revisions sample quality that was acceptable in 2000, 
may not have been unacceptable in 2007. Because of the various changes in 
product vendors and method procedures the samples themselves would not 
have been processed the same over the course of the revisions. In order to 
reduce some of the bias effect this may have caused only samples that were 
  
23
simultaneously tested for Cryptosporidium and Giardia were analyzed. To 
minimize possible detection bias only the overall results of positive (cysts or 
oocysts detected) and negative (no cysts or oocysts detected) were used, overall 
organism count and organism viability were not factored into the results.  
 Only sample results for samples that were simultaneously examined for 
Cryptosporidium and Giardia were used in this study. The EPA ICR Protozoan 
Method and the EPA Method 1623 are the rules that explicitly cover this type of 
analysis and detection. In the earlier ICR Protozoan Method a large volume of 
water is passed through a yarn-wound filter. Protozoa are eluted from the filter 
and cysts and oocysts are separated from other particulate debris by flotation on 
a Percoll-sucrose solution. The water layer/Percoll-sucrose interface is placed on 
a membrane filter, stained, and then examined under a microscope. A major 
drawback to this method is that it is a very time consuming process.  
 An advanced protozoan detection method, Method 1623, was created as 
a performance based method, meaning that modifications of the method may be 
used if they show equivalent or better performance. For this method a sample of 
approximately 10 liters is pumped through an approved 1-micron membrane 
filter. The filters are submitted to an approved lab for analysis. To retard any 
degradation of cysts or oocysts captured on the filter samples are shipped on ice 
and stored in a cooler prior to analysis. Within 96 hours of sample collection 
filters are eluted with an aqueous buffered salt and detergent solution to wash 
cysts and oocysts from the filter. The eluate is then concentrated and purified. 
Magnetic beads that are conjugated to antibodies for Cryptosporidium and 
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Giardia are added to the concentrate along with buffering agents and the mixture 
is then rotated. After rotation a magnetic particle concentrator is used to separate 
the magnetized cysts and oocysts from extraneous material. The resulting 
bead/cyst bead/oocysts complexes are washed with acid to dissociate the cysts 
and oocysts from the beads. The now purified sample is applied to a slide with a 
small amount of base solution and allowed to dry. Within 72 hours of application 
of purified sample to the slide the slide is stained with fluorescently labeled 
monoclonal antibodies to Cryptosporidium and to Giardia and 4’,6-diamidino-2-
phenylindole (DAPI). The stained sample slide is then examined within 7 days by 
an experienced laboratory technician using epifluorescence and differential 
interference contrast (DIC) microscopy. The results of the slides are recorded 
and reported.  
 The ICR Protozoan Method and Method 1623 have similar limitations: 
neither method is able to identify the species of organism or the host species; 
organic and inorganic debris can interfere with the sample analysis; organisms 
and debris that fluoresce can interfere with cyst and oocysts microscopic 
detection; freezing of the sample, filter, eluate, concentrate, or slides can 
interfere with detection; and inappropriately maintained laboratory equipment can 
affect detection. An advancement of the Method 1623 is that with the DAPI 
staining it is possible to determine the viability of detected cysts and oocysts 
whereas the ICR Protozoan Method cannot. 
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Results and Discussion 
 Due to current state regulations positive tests necessitate multiple further 
samples be submitted for testing. It follows that original effluent quality is a major 
determinant in the number of samples submitted. To examine if this was in fact 
true, a comparison of the number of positive samples to the overall number of 
samples submitted for each county was done. The data was fit to a linear 
regression line with a 0.78 coefficient of correlation. A considerable positive 
correlation between the number of positive samples and the overall number of 
samples submitted per county exists. Another comparison of the percent positive 
samples to the overall number of sample submitted for each county was done. 
This yielded a coefficient of correlation of 0.02 for this data set. This suggests 
that the most significant relation between a county having positive samples is the 
overall number of samples submitted, with the percent positive having little to no 
significant relation.   
 Each sample submitted was simultaneously tested for Cryptosporidium  
oocysts and Giardia cysts. Therefore each sample had two results but for the 
purpose of analysis was only considered as a single sample. In order to more 
accurately reflect this in the results the data for certain analysis was grouped 
together. As seen in Table 1 of the 863 samples submitted Cryptosporidium 
oocysts were detected in 52% and Giardia cysts were detected in 65% of the 
samples. For 99% of the samples that had Giardia cysts detected, 
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Cryptosporidium oocysts were also detected. For almost every county Giardia 
cysts were detected in more wastewater effluent samples than Cryptosporidium 
oocysts and the occurrence of Giardiasis was higher than that of 
Cryptosporidiosis. This is easily explained by two facts 1) Giardiasis has long 
been a disease with a much higher incidence and prevalence than 
Cryptosporidiosis and 2) Cryptosporidium oocysts are harder to detect than 
Giardia cysts. 
 
Table 1. A comparison of the percent of samples testing positive for detection of 
Cryptosporidium oocysts and/or Giardia cysts for all samples submitted for 
Cryptosporidium and Giardia testing (1998 – 2010). 
Comparison of the Percent Positive Samples for All Samples Submitted for 
Cryptosporidium and Giardia Testing  
(1998 – 2010) 
 Percent Positive 
Cryptosporidium 52% 
Giardia 65% 
 
 A comparative analysis of results to determine if a significant difference in 
detection was noted with respect to sample collection and analysis method for 
the ICR Protozoan Method and Method 1623 was attempted. Due to lack of 
information for collection and analysis method for specific samples an exact 
analysis of the difference in methods was not possible. However, in the first 
years of sampling the prevalent method was the ICR Protozoan Method with 
Method 1623 being the prominent method in recent years. Thus in an attempt to 
analyze a possible difference in the efficacy of detection methods sampling data 
from 1998 to 2001 was compared with sampling data from 2009 to 2010. In 
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Table 2 this data, including the different percents positive, for samples submitted 
for testing is presented. For the time periods the 2009 to 2010 period had an 
overall percent positive of 73.0 % compared to that of 36.7 % for 1998 to 2001. 
This difference suggests that the detection methods, the ICR Protozoan Method 
and Method 1623, may play a role in the detection of oocysts and cysts in the 
samples. This does not rule out the possibility that during that amount of time the 
actual presence of oocysts and cysts increased. A list of the counties submitting 
samples for the two time periods is available in Appendix E.  
Table 2. A comparison of counties submitting samples for Cryptosporidium and 
Giardia testing by number of counties submitting samples, total number of 
sample submitted, overall percent positive for all counties, and the percent 
positive of the 18 counties that submitted samples for 1998 to 2001 and for 2009 
to 2010. 
Data for All Samples Submitted for Cryptosporidium and Giardia Testing for 
1998 to 2001 Compared to That of 2009 to 2010 
 1998 - 2001 2009 - 2010 
Number of Counties 
Submitting Samples 20 33 
Total Number of Samples 
Submitted for Testing 166 248 
Overall Percent Positive of 
All Counties 36.7 % 73.0 % 
Percent Positive of the 
Same 18 Counties 37.0 % 69.5 % 
  
Of the 67 counties in Florida: 27 did not submit any samples; of the 40 counties 
that did submit samples 15 counties submitted ten or less samples; and only 
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Hillsborough, Pinellas, Sarasota, and Volusia counties submitted over 50 
samples. It is incredibly important to note the 40 counties that did not account for 
any samples. In Florida there are currently over 3,700 individually permitted 
wastewater facilities. Treatment facilities not under the influence of surface water, 
that serve less than 10,000 people, and that are filtered are not necessarily 
required to submit samples. The samples in this study were collected from 234 
wastewater facilities. A limitation of this study is that it only had test results for 
approximately 5% of the wastewater treatment facilities in Florida. Analysis of the 
difference between the variables examined for the facilities that submitted 
samples versus those that did not was unable to be done. It is possible that 
significant information on the efficacy of treatment and filtration methods is 
therefore undetected. 
 The number of facilities in any area depends on the water usage and 
consumption for that area as well as the capacity of the facilities in that area. The 
amount of wastewater produced is directly proportional to the water use in an 
area. Because water usage is a function of the population of an area the rate of 
samples submitted per 100,000 people per county could demonstrate if the 
population of a county could be the most important determiner in the number of 
samples submitted for that county. This accounts for the difference of population 
density of the areas submitting samples. Figure 1 is a graph of the rate of 
samples submitted for Cryptosporidium and Giardia testing per 100,000 people 
per county (1998-2010). As previously described the population information was 
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taken from Florida CHARTS. The data used was an average of the population in 
each county per year for the years 1999 to 2010. 
 If the factors affecting the effluent quality of wastewater treatment facilities 
were equivalent the rate of samples per 100,000 people per county would be 
similar. Figure 1 demonstrates that there is a difference, but not does not 
demonstrate the reason for the difference. This difference could be explained by 
the number of facilities submitting samples and the size of facilities submitting 
samples. In an effort to examine if there was an obvious geographic link to the 
distribution of counties in which a higher rate of samples was submitted a map of 
Florida counties with the associated rate was made, this is represented in Figure 
2. There was no obvious link between the geographical location of a county and 
the rate of samples that were submitted in that county per 100,000 people. Some 
counties that have the larger populations are among the counties submitting the 
lower numbers of samples, such as Monroe, Miami-Dade, Palm Beach, Duval, 
Hillsborough, and Pinellas counties. A possible explanation for this is that 
counties with larger populations have facilities that account for a greater 
proportion of the population. It is also possible that counties with greater 
populations have better means of maintaining their treatment facilities. 
Comparing Figure 2 and Figure 3 shows that counties with higher rates of 
samples submitted are not always the counties with the greater number of 
facilities submitting samples. This leads to the conclusion that there may be a 
difference between the sizes of the facilities or that certain counties with larger 
populations are better able to maintain their treatment facilities. 
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Rate of Samples Submitted for Cryptosporidium  and Giardia  Testing per 100,000 
People per County (1998-2010)
Figure 1. Rate of samples submitted for Cryptosporidium and Giardia testing per 
100,000 people per county 1998-2010. The population used was an average 
population for each county for 1998 through 2010.  
 
 A comparison of the rate of samples submitted for Cryptosporidium and 
Giardia per 100,000 for each county versus the rate for each watershed was not 
able to be done. There was no population information available for the watershed 
to do a rate comparison with.  
 Figure 3 is a map of the number of facilities submitting samples for 
Cryptosporidium and Giardia testing per county for 1998 through 2010. A 
calculation for the rate of facilities submitting samples per 100,000 for each 
county was unable to be done due to limitations of the data available. There was 
no distinct pattern of the number of facilities that submitted samples per county 
seen on the map in Figure 3.  
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Figure 2. Map of Rate of samples submitted for Cryptosporidium and Giardia 
testing per 100,000 people per county 1998-2010. The population used was an 
average population for each county for 1998 through 2010. 
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Figure 3. Map of the number of facilities submitting samples for Cryptosporidium 
and Giardia testing per county for 1998 through 2010.  
 
 The map of the number of facilities submitting samples for 
Cryptosporidium and Giardia testing per watershed for 1998 through 2010, 
Figure 4, also shows no distinct pattern of distribution for the areas submitting a 
greater number of samples. However, the map demonstrates that for the 
southern tip of Florida a wide area of the Florida Everglades accounts for an area 
where no samples were taken from. Much of this area is either rural, agricultural, 
or protected land with no or few wastewater treatment plants and is therefore not 
expected to be submitting samples for testing. When comparing this with Figure 
3 it demonstrates the idea that for certain areas where there is a greater 
population, such as coastal south Florida, there will be more facilities submitting 
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samples. The corresponding watersheds for areas with high sample levels show 
this distinct division between coastal areas and inland areas. A watershed is 
defined as an area or region that is drained by a river, river system, or other body 
of water. This means that watersheds right next to each other will have waters 
that flow into different rivers, basins, or bodies of water. When a river or lake is 
contaminated by wastewater effluent that has cysts and/or oocysts in it the entire 
watershed it resides in is at an increased risk of becoming contaminated. If a 
specific county had a greater number of samples submitted by a small number of 
facilities it could be inferred that the facilities were then unable to appropriately 
treat their water. 
 Of the 29 main watersheds in Florida three did not have any samples 
submitted: Chipola River, Fisheating Creek, and Perdido River. Figure 5 is a map 
of the distribution of the number of samples submitted for Cryptosporidium and 
Giardia testing per watershed between 1998 and 2010. 
 When examining Figures 4 and 5 it is apparent that the watersheds where 
there were a greater number of samples collected coincided with the areas 
where there were a greater number of facilities that submitted samples for 
Cryptosporidium and Giardia testing. This also demonstrates that in the 
watersheds the areas where a greater number of samples were submitted did not 
have a small number of facilities accounting for the samples.  
 Three different filtration methods, continuous backwash (18.8%), deep 
bed multi media (20.7%), and shallow bed backwash (36.9%), accounted for 
76.4% of the total samples. Of the remaining samples nine different filtration 
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methods were used, due to the small number of facilities utilizing these methods 
no further analyses was performed on those filtration methods. 
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Figure 4. Map of the number of facilities submitting samples for Cryptosporidium 
and Giardia testing by watershed for 1998 through 2010. 
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Figure 5. Map of the distribution of the number of samples submitted for 
Cryptosporidium and Giardia testing per watershed between 1998 and 2010. 
  
 Continuous backwash, deep bed multi media, and shallow bed backwash 
filtration systems had similar positive percentage rates of detection for 
Cryptosporidium and/or Giardia of 58.3%, 52.6%, and 59.8%, respectively. The 
differences in the percentages where not large enough to be considered 
statistically significant:  p-values were all greater than 0.5, meaning the 
hypothesis that they were not significantly different was correct.   
 When examining the distribution of the three main filtration methods by 
county Figures 6A and 6B shows that all three filtration methods had some 
overlapping areas of numbers of facilities submitting samples. The number of 
facilities within each county that used continuous backwash filtration, deep-bed 
multi media filtration, and shallow-bed automatic backwash were grouped to 
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compare whether any area had a more prominent number of a specific filtration 
method, this is shown in Figure 6A. In order to examine a geographic pattern of 
the distribution of the three different filtration methods a map of the information in 
Figure 6A was made, Figure 6B.  
 When comparing the percent positive and areas of location of different 
filtration methods in place no discernable pattern emerged as to one filtration 
method having better or worse detection limits or geographical association.  
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Continuous Backwash Filtration Deep bed, multiple media Shallow bed, automatic backwash
Figure 6A.  The number of facilities per county for the three different filtration 
methods of continuous backwash, deep-bed multiple media, and shallow-bed 
automatic backwash grouped together.  
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Figure 6B.  Distribution of the number of facilities per county for the three 
different filtration methods of continuous backwash, deep-bed multiple media, 
and shallow-bed automatic backwash grouped together.  
 
 A comparison was done for the four laboratories where the greatest 
number of samples submitted for Cryptosporidium and Giardia testing were 
analyzed. Figure 7 shows the overall number of samples that were negative, 
number of samples that were positive, and the percent positive of samples for 
those laboratories. The frequency of detection of cysts and oocysts could be a 
function of the specific lab that did the analysis. Each facility did not submit 
samples to the same laboratory for testing each time a sample was taken. This 
eliminates some of the bias present for each facility specifically accounting for 
positive samples. There were 11 laboratories that analyzed samples. Of those 11 
only four laboratories had analyzed enough samples to be statistically 
comparable. These labs will be referred to as Laboratory A (a county water 
utility), B (a commercial laboratory), C (a state public health laboratory), and D (a 
university laboratory).  The percent positive of samples was not statistically 
significant between Laboratory A and Laboratory C (p-value = 0.15). There was a 
Continuous Backwash Filtration Deep bed, multiple media Shallow bed, automatic backwash
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significant difference in the percent positive of samples between Laboratory A 
and Laboratory B (p-value < 0.0001), as well as Between Laboratory B and 
Laboratory C (p-value < 0.0001).  Laboratory D had a significant difference from 
all of the others labs, but was statistically closer to the results from Laboratory C 
than any other laboratory. Of these results the most intriguing is that of the 
differences between Laboratories A, B, and C. Laboratory C analyzed a greater 
quantity of samples but still had a similar percent positive to that of Laboratory A. 
Laboratory B had a significantly smaller percent positive than all the other labs. 
These results point towards a significant difference in the number of samples in 
which oocysts and cysts are detected depending on the laboratory analyzing the 
samples. Tying these results in with those shown in Table 2 a cause of the 
significant difference in the percent positives of samples may be the laboratory 
that does the testing as well as which method of detection that laboratory utilizes.  
Results of Samples Submitted for Cryptosporidium  and Giardia  Testing per 
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Figure 7.  The overall number of samples that were negative, number of samples 
that were positive, and the percent positive of samples for Laboratory A, 
Laboratory B, Laboratory C, and Laboratory D. 
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 Because of the health risks posed by wastewater contaminated with 
Cryptosporidium oocysts and Giardia cysts the rates of samples positive for each 
county were compared with the rates of cryptosporidiosis and giardiasis for 1998 
through 2010, see Figure 8 for rate of cryptosporidiosis and Figure 9 for 
giardiasis.  As described previously, the rates of cryptosporidiosis and giardiasis 
for all Florida counties were obtained from Florida Charts. Madison County was 
the only county that had no reported cases of cryptosporidiosis and has one of 
the smallest levels of Giardiasis. A possible explanation for this is human to 
human spread of disease as opposed to individual cases all being caused by 
contact with contaminated water. 
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Figure 8.  Map of the average rate of cryptosporidiosis per 100,000 people by 
county during 1998 through 2010.  
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Figure 9.  Map of the average rate of giardiasis per 100,000 people by county 
during 1998 through 2010.  
 
 The quality of effluent water from wastewater treatment facilities in Florida 
varies by county and by watershed. When examining the rate of samples 
submitted for a county and the rate of disease of that county there seems to be 
an almost inverse proportion. This would seem to suggest that areas in which 
there is a higher burden of disease may be in areas where it seems that the 
facilities do not need to do sample testing or are areas in which there are no 
large treatment facilities that are required to submit samples for testing. This 
could also mean that areas with smaller treatment facilities that are not required 
to submit samples under the current rule do, in fact, need to be doing sample 
testing. It could also suggest that in areas that the quality of the effluent 
wastewater is inadequate, as evidenced by detection of cysts and oocysts, the 
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route of transmission for the disease is not necessarily from contaminated 
wastewater effluent but possibly human to human contact. It is evident that 
further monitoring of the differences between laboratories analyzing samples, as 
well as the method of analysis, is needed.  
 Significant public health risks are still posed by Cryptosporidium and 
Giardia, further monitoring and evaluation of source water treatment and filtration 
methods is necessary to accurately address their levels in water supplies.  
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Appendices 
 
 
Appendix A. List of Florida Counties 
 
Alachua 
Baker 
Bay 
Bradford 
Brevard 
Broward 
Calhoun 
Charlotte 
Citrus 
Clay 
Collier 
Columbia 
DeSoto 
Dixie 
Duval 
Escambia 
Flagler 
Franklin 
Gadsden 
Gilchrist 
Glades 
Gulf 
Hamilton 
Hardee 
Hendry 
Hernando 
Highlands 
Hillsborough 
Holmes 
Indian River 
Jackson 
Jefferson 
Lafayette 
Lake 
Lee 
Leon 
Levy 
Liberty 
Madison 
Manatee 
Marion 
Martin 
Miami-Dade 
Monroe 
Nassau 
Okaloosa 
Okeechobee 
Orange 
Osceola 
Palm Beach 
Pasco 
Pinellas 
Polk 
Putnam 
Saint Johns 
Saint Lucie 
Santa Rosa 
Sarasota 
Seminole 
Sumter 
Suwannee 
Taylor 
Union 
Volusia 
Wakulla 
Walton 
Washington
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Appendix B. Map of Florida Counties 
 
 
Figure A1. Map of Florida Counties 
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Appendix C. List of Florida Watersheds 
 
 
Apalachicola – Chipola 
Caloosahatchee 
Charlotte Harbor 
Choctawhatchee – St. Andrew 
Everglades 
Everglades West Coast 
Fisheating Creek 
Florida Keys 
Indian River Lagoon 
Kissimmee River 
Lake Okeechobee 
Lake Worth Lagoon – Palm Beach Coast 
Lower St. Johns Nassau – St. Marys 
Middle St. Johns 
Ocklawaha 
Ochlockonee – St. Marks 
Pensacola 
Perdido 
St. Lucie – Loxahatchee 
Sarasota Bay – Peace - Myakka 
Springs Coast 
Southeast Coast – Biscayne Bay 
Suwannee 
Tampa Bay 
Tampa Bay Tributaries 
Upper East Coast 
Upper St. Johns 
Withlacoochee 
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Appendix D. Map of Florida Watersheds 
 
 
 
Figure A2. Map of Florida Watersheds 
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Appendix E. Lists of Counties Submitting Samples for Cryptosporidium 
and Giardia Testing for 1998 to 2001 and 2009 to 2010 
 
1998 to 2001   2009 to 2010 
Bay     Alachua 
Brevard    Bay 
Charlotte    Brevard 
DeSoto    Broward 
Duval     Charlotte 
Hillsborough    Collier 
Lee     DeSoto
Manatee    Duval 
Martin     Hernando 
Okaloosa    Hillsborough 
Osceola    Indian River 
Palm Beach    Lake 
Pasco     Lee 
Pinellas    Manatee 
Polk     Marion 
Santa Rosa    Martin 
Sarasota    Miami-Dade 
Seminole    Nassau 
Sumter    Orange 
Volusia    Osceola 
     Palm Beach 
     Pasco 
     Pinellas 
     Putnam 
     Saint Johns 
     Saint Lucie 
     Santa Rosa 
     Sarasota 
     Seminole 
     Sumter 
     Volusia 
     Wakulla 
     Walton 
